tiprankstipranks
Jacobio Pharmaceuticals Group Co., Ltd. (HK:1167)
:1167
Hong Kong Market

Jacobio Pharmaceuticals Group Co., Ltd. (1167) Price & Analysis

Compare
3 Followers

1167 Stock Chart & Stats


---

Financials

Quarterly

Options Prices

Currently, No data available
---

Ownership Overview

0.48%99.51%
Insiders
― Other Institutional Investors
99.51% Public Companies and
Individual Investors

1167 FAQ

What was Jacobio Pharmaceuticals Group Co., Ltd.’s price range in the past 12 months?
Jacobio Pharmaceuticals Group Co., Ltd. lowest stock price was HK$1.20 and its highest was HK$2.90 in the past 12 months.
    What is Jacobio Pharmaceuticals Group Co., Ltd.’s market cap?
    Jacobio Pharmaceuticals Group Co., Ltd.’s market cap is HK$1.56B.
      When is Jacobio Pharmaceuticals Group Co., Ltd.’s upcoming earnings report date?
      Jacobio Pharmaceuticals Group Co., Ltd.’s upcoming earnings report date is Mar 26, 2025 which is in 30 days.
        How were Jacobio Pharmaceuticals Group Co., Ltd.’s earnings last quarter?
        Jacobio Pharmaceuticals Group Co., Ltd. released its earnings results on Aug 30, 2024. The company reported -HK$0.236 earnings per share for the quarter, beating the consensus estimate of -HK$0.289 by HK$0.054.
          Is Jacobio Pharmaceuticals Group Co., Ltd. overvalued?
          According to Wall Street analysts Jacobio Pharmaceuticals Group Co., Ltd.’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
            Does Jacobio Pharmaceuticals Group Co., Ltd. pay dividends?
            Jacobio Pharmaceuticals Group Co., Ltd. does not currently pay dividends.
            What is Jacobio Pharmaceuticals Group Co., Ltd.’s EPS estimate?
            Jacobio Pharmaceuticals Group Co., Ltd.’s EPS estimate is 0.05.
              How many shares outstanding does Jacobio Pharmaceuticals Group Co., Ltd. have?
              Jacobio Pharmaceuticals Group Co., Ltd. has 791,755,070 shares outstanding.
                What happened to Jacobio Pharmaceuticals Group Co., Ltd.’s price movement after its last earnings report?
                Jacobio Pharmaceuticals Group Co., Ltd. reported an EPS of -HK$0.236 in its last earnings report, beating expectations of -HK$0.289. Following the earnings report the stock price went up 5.031%.
                  Which hedge fund is a major shareholder of Jacobio Pharmaceuticals Group Co., Ltd.?
                  Currently, no hedge funds are holding shares in HK:1167
                  ---

                  Jacobio Pharmaceuticals Group Co., Ltd. Stock Smart Score

                  Company Description

                  Jacobio Pharmaceuticals Group Co., Ltd.

                  Jacobio Pharmaceuticals Group Co Ltd is a clinical-stage pharmaceutical company focusing on the in-house discovery and development of innovative oncology therapies.
                  ---

                  1167 Stock 12 Month Forecast

                  Average Price Target

                  HK$1.85
                  ▼(-6.09% Downside)
                  {"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"0":"HK$0","3":"HK$3","6":"HK$6","1.5":"HK$1.5","4.5":"HK$4.5"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":1.85,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">HK$1.85</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":1.85,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">HK$1.85</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":1.85,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">HK$1.85</span>\n  </div></div>","useHTML":true}}],"tickPositions":[0,1.5,3,4.5,6],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Oct<br/>2023","6":"Jan<br/>2024","9":"Apr<br/>2024","12":"Feb<br/>2025","25":"Feb<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,1.39,1.4253846153846153,1.4607692307692306,1.4961538461538462,1.5315384615384615,1.5669230769230769,1.6023076923076922,1.6376923076923076,1.6730769230769231,1.7084615384615385,1.7438461538461538,1.7792307692307694,1.8146153846153847,{"y":1.85,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,1.39,1.4253846153846153,1.4607692307692306,1.4961538461538462,1.5315384615384615,1.5669230769230769,1.6023076923076922,1.6376923076923076,1.6730769230769231,1.7084615384615385,1.7438461538461538,1.7792307692307694,1.8146153846153847,{"y":1.85,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,1.39,1.4253846153846153,1.4607692307692306,1.4961538461538462,1.5315384615384615,1.5669230769230769,1.6023076923076922,1.6376923076923076,1.6730769230769231,1.7084615384615385,1.7438461538461538,1.7792307692307694,1.8146153846153847,{"y":1.85,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":5.88,"date":1688169600000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":4.76,"date":1690848000000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":3.81,"date":1693526400000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":3.2,"date":1696118400000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":3.74,"date":1698796800000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":3.64,"date":1701388800000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":3.62,"date":1704067200000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":2.5,"date":1706745600000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":2.65,"date":1709251200000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":1.65,"date":1711929600000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":1.65,"date":1711929600000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":1.74,"date":1725148800000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":1.39,"date":1738368000000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
                  Similar Stocks
                  Company
                  Price & Change
                  Follow
                  Wuxi Biologics (Cayman)
                  Antengene Corporation Limited
                  Akeso, Inc.
                  Viva Biotech Holdings
                  Vanov Holdings Company Limited

                  Best Analysts Covering 1167

                  1 Year
                  No data currently available
                  Popular Stocks
                  ---
                  What am I Missing?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis